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Abstract The aim of the study was to evaluate zinc levels in three biological compartments
(serum, erythrocytes and hair) in patients with rheumatoid arthritis (RA) as compared to
healthy individuals. Zinc levels in serum, erythrocytes and hair (in 74 patients with RA and
30 healthy individuals) were assessed by atomic absorption spectroscopy. The mean hair
zinc content was significantly lower in RA patients as compared to healthy individuals (p<
0.001). Moreover, a positive correlation was observed in the RA patient group between the
erythrocyte zinc levels and the prednisone dose (rs=0.48, p<0.05), and a negative
correlation was found in this population between the serum zinc levels and disease duration
(rs=−0.42, p<0.0006). In conclusion, it seems that hair may be a useful complementary
study material for evaluating “zinc status” in rheumatoid arthritis patients.
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Introduction
Rheumatoid arthritis (RA) is a well-studied progressive autoimmune disease. However, no
factor responsible for the immune system activation in the course of the disease has been
identified to date [1]. Among the many contributing agents that have been proposed to take
part in the pathogenesis of this condition, trace elements, including zinc, have also been
investigated [2–5]. The evidence for their involvement stems from the observation that
postmenopausal women consuming higher amounts of zinc are at a lower risk of RA (RR=
0.39, 95% CI=0.17–0.88, p<0.03) [6].
It has been shown that reactive oxygen species play a role in the aetiology of RA [1, 6–
10] and that one of them is the superoxide radical, which is eliminated by superoxide
dismutase—an enzyme containing zinc in its molecule [3, 5, 11]. It has also been found that
over 90% of this trace element present in erythrocytes is bound with carbonic anhydrase
and superoxide dismutase [12]. Furthermore, zinc mobilises vitamin A, a potent
antioxidant, from the liver, thus maintaining its proper levels in the blood [11].
Zinc is crucial for the proper functioning of approximately 300 hormones and enzymes in
the human body [11, 12], the latter representing all the classes taking part in the synthesis and
degradation of proteins, carbohydrates, fats and nucleic acids. Zinc constitutes a structural
element of alkaline phosphatase (ALP), with four of its atoms being present in the enzyme.
Zinc also stimulates ALP synthesis in osteoblasts and plays an important role in bone
mineralisation [13]. In addition, zinc is responsible for the latency of metalloproteinases (such
as collagenases, gelatinases, stromelysins, matrilysin, metalloelastases and membrane
metalloproteinases) by means of a coordination bond between a zinc atom in the centre of
the enzyme and a free cysteine–SH group present in the pro-peptide. Notably, the breaking of
this bond and the release of the pro-peptide result in the activation of metalloproteinases
responsible for articular cartilage destruction observed in RA [11, 12, 14].
Zinc deficiency has been previously studied in an experimental human model involving
males on a low-zinc diet (mild zinc deficiency) [15]. The reported effects included lowered
plasma testosterone levels, oligozoospermia, decreased natural killer cell function, reduced
interleukin 2 production, low thymulin levels, hyperammonaemia, diminished sensitivity to
different tastes, impaired adaptation to the dark and decreased lean body mass.
The investigators’ opinions on the zinc status in the human body vary, particularly in respect
to this element’s serum, plasma and erythrocyte levels. Relatively few publications addressing
the zinc content in hair are available [16–19], and there seems to be no reports on its
assessment in RA patients. Thus, the authors of the present study undertook the task of
evaluating the content of this bioelement in serum, erythrocytes as well as hair of patients
with rheumatoid arthritis.
The aim of this work was to examine the differences between the levels of zinc present
in three fundamental biological compartments in patients with RA and in healthy
individuals, with a particular focus on hair.
Material and Methods
Study Population
Seventy-four patients treated for RA were evaluated in two specialist Rheumatology
Outpatient Clinics in Szczecin, Poland. The studied group comprised 20 men and 54
women aged 29–50 (mean age, 39.8±6.1 years). The diagnosis of RA was based on
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meeting at least four of the seven criteria given by the American College of Rheumatology
[20].
RA patients were divided into four subgroups (listed below) depending on the received
pharmacological treatment during the previous 6 months prior to the study:
& MTX=patients treated with methotrexate (MTX) at a weekly dose range from 7.5 to
12.5 mg/week and non-steroidal anti-inflammatory drugs (NSAIDs);
& MTX+GC=patients treated as above but also receiving glucocorticoids (GC),
prednisone, at a dose of 5.0–12.5 mg daily;
& MTX+GC+Ca+D3=patients treated as above but also receiving calcium and vitamin
D3 (as means of preventing osteoporosis); and
& SAS=patients receiving sulphasalazine (SAS) at a dose of 1,500–2,000 mg/daily and
NSAIDs only.
The control group consisted of 30 healthy individuals reporting successively to the clinic
of two general practitioners in Szczecin for reasons unrelated to RA. This group comprised
8 men and 22 women aged 27–50 (mean age, 38.2±8.3 years).
The inclusion criteria applied to both groups were as follows:
1. No diuretics, hypotensive agents, anticonvulsants, antibiotics, vitamin supplements
containing studied elements or oral contraceptives (females) taken for at least 6 months
prior to the study;
2. Nutrition—following a normal diet;
3. No evident gastrointestinal or urinary disturbances or endocrine conditions;
4. Age below 50 and regular menstruation (females); and
5. Informed consent to take part in the study.
Study Design
All study participants had their medical history taken and underwent a physical examination
and had their zinc levels measured: in the extracellular fluid (serum) and in the intracellular
compartment (erythrocytes and hair).
The study has been accepted by the Bioethical Commission (Ethics Board) of the
Pomeranian Medical University in Szczecin for studies in human subjects.
Written informed consent was obtained from all patients from both study and control groups.
Biochemical Analysis
Serum and Erythrocyte Zinc Levels
Zinc levels in serum and in erythrocytes were measured by atomic absorption spectroscopy
(AAS) using either an acetylene–air or acetylene–nitrous oxide flame. The serum and erythrocyte
samples were prepared by mineralisation in a 5:2 mixture of ultrapure nitric acid and perchloric
acid until achieving complete destruction of the organic matrix. Next, the solution was transferred
quantitatively into a volumetric flask and filled up to the final volume with deionised water.
Hair Zinc Content
Hair sections of 3–4 cm in length, measured from the skin, were collected from six to eight
scalp regions with stainless steel scissors to avoid contamination with other heavy metals.
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The total hair sample weight was 0.2–0.3 g. For at least 6 months prior to the study, no hair
treatment was applied that might potentially alter the biological hair content of the studied
bioelements (the hair was not dyed, permanent waved, conditioned, etc.). The hair samples
were washed with a water solution of non-metal detergent, rinsed with deionised water and
dried at 60°C. Next, they were rewashed with a mixture of anhydrous alcohol and acetone
for 25 min, dried at 60°C and placed in a desiccator for 24 h. Subsequently, the hair
samples were weighed using analytical scales and subjected to mineralisation with a
mixture of ultrapure concentrated nitric acid and perchloric acid at a ratio of 5:2 (v/v). The
mineralisation process was conducted at the boiling point of the acid mixture, with water
and excess acids being distilled off to approximately one third of the original sample
volume. The remaining solution was transferred quantitatively to 25-cm3 glass flasks and
filled to volume with water distilled three times with a quartz distillation apparatus [23].
The zinc content was assessed by AAS using either an acetylene–air or acetylene–nitrous
oxide flame. The measurements were conducted with a Pay-Unicam SP-9 spectrophotometer
interfaced with a computer.
The levels of zinc in serum, erythrocytes and hair were analysed at the Institute of
Quantum Electronics, Military Technical Academy, Warsaw, Poland.
Statistical Analysis
Statistical analysis was performed using the StatSoft Polska v. 9.0 package (StatSoft Inc.,
Tulsa, Oklahoma, USA).
The distribution type of the studied parameters within the analysed groups was
determined based on the Shapiro–Wilk test for normality (N), sample size (n), range of
values (range), median (Me), mean xð Þ and standard deviation (SD). The results from two
independent groups were compared using the Student’s t test (when the distribution of a
given parameter was not significantly different statistically from the normal distribution in
any of the comparison groups) or the Mann–Whitney U test (when the distribution of a
given parameter was significantly different statistically from the normal distribution in at
least one of the groups being compared).
In order to determine a statistical relationship between two variables, either the Pearson’s
(linear) correlation coefficient (when both variables had normal distribution) or Spearman’s
rank correlation coefficient (with at least one variable not having the normal distribution)
were used.
In all comparisons, the adopted significance threshold was p value ≤0.05.
Results
Table 1 shows the distribution patterns of the quantitative parameters in RA patients: mean
disease duration, RA clinical activity such as the Ritchie articular index for joint tenderness
[21] as well as the subjective joint pain score based on the visual analogue scale (VAS), and
haematology test results for erythrocyte sedimentation rate (ESR) and haemoglobin (Hb)
level. Additionally, the disease activity of RA was determined with the disease activity
score including 28 joints using ESR (DAS28-ESR) [22].
Table 2 presents the comparison of zinc levels in serum, erythrocytes and hair from
patients with RA and from healthy individuals. Statistically significant lower zinc
levels were found in RA patients versus control group, but only for the hair
compartment (p<0.001).
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Within the RA patient group, no statistically significant differences were found in the
zinc levels between the treatment subgroups irrespective of the evaluated biological
compartment (Table 3).
Table 4 presents the values of Spearman’s rank correlation coefficients (rs) for statistical
dependence between the zinc levels in studied biological compartments and the doses of
administered MTX and prednisone (GC). A positive correlation was observed between the
erythrocyte zinc levels and the glucocorticoid dose (rs=0.48, p<0.05).
Table 5 presents the relationship between the evaluated parameters and the levels of zinc in
each of the biological compartments. The only statistically significant correlation (a negative
one) was observed between the serum zinc levels and the disease duration (rs=−0.42, p<
0.0006). No correlation was established between the zinc levels in the analysed biological
compartments and disease activity determined by DAS28.
Discussion
Our evaluation of the zinc content in the hair of patients with RA is a pioneering study on
“zinc status” in RA patients. The available literature offers reports focussing solely on the
examination of zinc levels in plasma/serum, urine and, rarely, in erythrocytes of patients
with RA [2, 24–29]. The hair is a practical material for conducting bioelement analysis
since, similar to skin, myocardium and skeletal muscles, it constitutes a more stable depot
of elements than blood serum or erythrocytes [11, 16, 17, 19, 23]. Growing at a rate of 1.0–
2.0 cm per month, hair along its entire length constitutes a specific reflection of all the
biochemical events occurring in the body [17, 18]. Unlike tissues, hair is the end metabolic
product, with various elements incorporated into its composition as it grows. Upon reaching
the skin surface, the hair hardens and keratinises, and the elements accumulated during its
formation become embedded in its protein structure [17]. The present study demonstrates
Table 1 Study group characteristics (patients with RA, n=74)
Parameter Normality of distribution Range Median Mean ± SD
Mean disease duration (years) − 1.0–28.0 7.7 8.5±6.7
Ritchie articular index (points) − 2.0–19.0 8.1 8.2±3.4
VAS (cm) − 2.0–8.5 5.2 5.1±1.7
ESR (mm/h) − 2.0–93.0 31.2 37.2±25.1
Hb (g/dL) + 10.5–15.1 12.7 12.8±0.9
DAS28 − 2.6–6.5 5.1 4.9±0.9
Table 2 Comparison of mean zinc levels in serum, erythrocytes and hair of patients with RA versus the
control group
Type of sample in which mean zinc
levels/content were assessed
RA patients (n=74) Control group (n=30) p value
Serum (μg/dL) 80.1±12.5 72.0±8.0 NS
Erythrocytes (μg/dL) 968.2±113.9 1008.9±46.9 NS
Hair (μg/g d.h.m.) 160.9±27.4 190.8±29.9 <0.001
d.h.m. dry hair mass
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that the hair zinc content in RA patients is significantly lower than that in healthy
individuals and is not dependent on the applied treatment regimen. It therefore seems that
the evaluation of the zinc content in hair could be a useful complementary diagnostic
method to determine “zinc status” in rheumatoid arthritis patients. Moreover, the fact that
this particular evaluation method is completely noninvasive is of significance.
The serum zinc level was also examined in the present study, following on from the fact
that it is the standard test for assessing the status of this element in the body. It was
demonstrated here, as by other authors previously [28, 29], that RA patients’ zinc levels in
this particular biological compartment are higher, albeit not statistically significantly, than
those in healthy individuals. This is surprising as the levels of this element in rheumatoid
arthritis should presumably be decreased, considering the fact that the pro-inflammatory
cytokines (IL-1 and TNF-α) [28] involved in the pathogenesis of this condition inhibit the
synthesis of albumins in the liver and decrease their zinc-binding capacity, which in turn
should lead to lower levels of plasma zinc [11]. Zoli et al. [5] have demonstrated this in
their studies, showing a negative correlation between the levels of IL-1β and TNF-α and
zinc levels. The authors have argued that the observed association results from the
accumulation of zinc in the liver and inflamed joints caused by elevated IL-1β. It seems
plausible that the lack of consistency in the available reported data may be due to the
rapidly changing plasma zinc levels influenced by such factors as diet, disease activity,
pharmacological therapy (e.g. the use of antibiotics, laxatives, diuretics, sedatives,
hypnotics and anticonvulsants) [24, 30]. Notably, oral contraceptives may also cause a
decrease in plasma zinc levels [12]. However, the present study did not show any
association between the level of zinc in patient’s serum and the type of applied
pharmacological treatment, although a negative, highly statistically significant correlation
Table 3 Comparison of mean zinc levels in patients with RA depending on the pharmacological treatment
used
Type of sample in which mean
zinc levels/content were assessed









Serum (μg/dL) 84.1±18.2 80.7±11.9 78.8±8.2 76.9±11.5 NS
Erythrocytes (μg/dL) 976.3±131.4 953.2±101.9 965.4±122.6 977.1±99.8 NS
Hair (μg/g d.h.m.) 146.9±40.9 153.4±13.1 163.7±25.8 179.7±29.7 NS
MTX methotrexate, GC prednisone, Ca calcium, D3 vitamin D3, SAS sulphasalazine, d.h.m. dry hair mass
Table 4 Correlation between the levels of zinc in serum, erythrocytes and hair and the doses of MTX or
prednisone (GC)
Type of sample in which mean zinc levels/content were assessed Spearman’s rank correlation coefficient
MTX (n=56) GC (n=37)
Serum (μg/dL) 0.14 0.04
Erythrocytes (μg/dL) 0.33 0.48*
Hair (μg/g d.h.m.) 0.40 −0.27
d.h.m. dry hair mass
*p<0.05
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between the serum zinc levels and the disease duration was observed. The latter is
consistent with findings reported by Çaglayan and Sükrü Aydog [25], suggesting that such
an effect may be partly due to secondary eating disorders often observed in chronic
inflammatory conditions.
There is a considerable amount of data demonstrating that plasma zinc constitutes <1% of its
total content in the body, with approximately 99% of this bioelement being located
intracellularly [12]. Taking this into consideration, the assessment of zinc level in erythrocytes
was also performed since these cells represent a more stable pool than serum and plasma [3,
26, 27]. Therefore, the examination of zinc levels in this biological compartment was
performed in the present study as well. The obtained results indicated that the erythrocyte
zinc levels might be lower in RA patients as compared to healthy individuals, but this
difference was not statistically significant. The small number of publications on zinc
concentrations in erythrocytes of RA patients provide inconsistent data, showing either higher
[3, 26] or lower levels [27] in comparison to control groups. Over 90% of zinc contained in
red blood cells is bound with superoxide dismutase and carbonic anhydrase [12]. Tuncer et al.
[3] have reported an increased activity of superoxide dismutase in the erythrocytes of RA
patients. The results obtained in the present study may reflect intensified utilisation of zinc by
red blood cells. On the other hand, animal studies have demonstrated an increased fragility of
erythrocytes due to low zinc content in their cell membranes [12]. This might lead to a
leakage of the intra-erythrocyte zinc pool into the extracellular space—an effect that could be
the underlying cause of the results obtained in the present study.
The positive correlation found in the present study between the dose of glucocorticoid
and erythrocyte zinc level may result from glucocorticoid action, the reduction and
consequent inactivation of active oxygen forms. Free oxygen radicals are known as lipid
peroxidation inductors, and the peroxidation of the lipids changes the structure and function
of cell membranes and inactivates cell membrane enzymes [1, 7].
Conclusion
It seems that the evaluation of zinc content in hair could be a useful complementary
diagnostic method to determine “zinc status” in rheumatoid arthritis patients. Still, our
Table 5 Values of Spearman’s rank correlation coefficients (rs) or Pearson’s (linear) correlation coefficients
(r) and levels of significance (p values) for the studied parameters in the group of patients with RA
Correlated parameters Type of sample in which mean zinc levels were assessed
Serum (μg/dL) Erythrocytes (μg/dL) Hair (μg/g d.h.m.)
Subject age (years) rs=−0.23 rs=−0.02 rs=−0.03
Mean disease duration (years) rs=−0.42* rs=0.09 rs=−0.01
Ritchie articular coefficient (score) rs= −0.11 rs=0.20 rs=−0.26
VAS (cm) rs=0.12 rs=0.07 rs=−0.26
ESR (mm/h) rs=0.03 rs=0.24 rs=0.08
Hb (g/dL) r=−0.17 r=0.03 r=−0.21
DAS28 rs=0.02 rs=0.33 rs=−0.08
d.h.m. dry hair mass
*p<0.0006
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results should be considered preliminary and no conclusions beyond the experimental study
phase should be drawn.
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